Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
10/30/2003 | WO2002084294A3 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
10/30/2003 | WO2002083882A3 Regulation of human serine/threonine protein kinase-like protein |
10/30/2003 | WO2002079444A3 Transgenic mice containing msk2 serine/threonine kinase gene disruptions |
10/30/2003 | WO2002074943A3 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains |
10/30/2003 | WO2002074788A3 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES |
10/30/2003 | WO2002072848A3 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
10/30/2003 | WO2002072758A3 Cytochrome p450s and uses thereof |
10/30/2003 | WO2002070663A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
10/30/2003 | WO2002070659A3 Production of polyhydroxyalkanoates |
10/30/2003 | WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
10/30/2003 | WO2002064762A3 Isolated polynucleotides encoding putative tyrosine kinase |
10/30/2003 | WO2002063030A3 Charge tags and separation of nucleic acid molecules |
10/30/2003 | WO2002061430A3 Methods and reagents for treating autoimmune disorders |
10/30/2003 | WO2002061050A3 Methods for determining ring number in carotenoids by lycopene epsilon-cyclases and uses thereof |
10/30/2003 | WO2002060474A3 Mixtures of mushroom enzymes and the use thereof for treating maldigestion |
10/30/2003 | WO2002059327A3 Sulfatases and methods of use thereof |
10/30/2003 | WO2002059283A3 Nucleic acid modification enzymes |
10/30/2003 | WO2002057476A3 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
10/30/2003 | WO2002053703A3 Aav2 vectors and methods |
10/30/2003 | WO2002050243A3 The use of ecm degrading enzymes for the improvement of cell transplantation |
10/30/2003 | WO2002028175A9 Transgenic mouse for targeted recombination mediated by modified cre-er |
10/30/2003 | WO2002022819A3 Calcium binding proteins |
10/30/2003 | WO2002010414A9 Expression of biologically active polypeptides in duckweed |
10/30/2003 | US20030204873 Generating genetically engineered herbicide resistant monocotyledons |
10/30/2003 | US20030204871 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position |
10/30/2003 | US20030204869 Method to control the ripening of papaya fruit and confer disease resistance to papaya plants |
10/30/2003 | US20030204865 CaaX prenyl protease nucleic acids and polypeptides and methods of use thereof |
10/30/2003 | US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases |
10/30/2003 | US20030204070 Polynucleotide encoding a novel methionine aminopeptidase, protease-39 |
10/30/2003 | US20030204069 Segments of the human gene for telomerase reverse transcriptase |
10/30/2003 | US20030204068 Nucleotide sequences coding campylobacter proteins for use in preventing bacterial, fungal and viral infection as well as treat gastrointestinal disorders and peptic ulcers; genetic vaccines |
10/30/2003 | US20030204054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy |
10/30/2003 | US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders |
10/30/2003 | US20030203987 Pigment containing ink and production method thereof |
10/30/2003 | US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes |
10/30/2003 | US20030203849 Composition promoting lacrimal secretion |
10/30/2003 | US20030203473 Microbial SUMO protease homologs |
10/30/2003 | US20030203468 Preparation of acariogenic sugar substitutes |
10/30/2003 | US20030203467 Novel variant EGIII-like cellulase compositions |
10/30/2003 | US20030203466 Comprises hydrolase for treating textiles, degrading plant biomass and fracturing subterranean formations |
10/30/2003 | US20030203465 DNA polymerase III holoenzyme |
10/30/2003 | US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
10/30/2003 | US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203455 Heat-stable D-aminoacylase |
10/30/2003 | US20030203451 Interleukin-17 (IL-17)/G-protein coupled receptors protein for use in diagnosis and treatment of cell proliferative, bone and inflammatory disorders |
10/30/2003 | US20030203449 Novel 2,5-diketo-L-gluconic acid reductases and methods of use |
10/30/2003 | US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
10/30/2003 | US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
10/30/2003 | US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
10/30/2003 | US20030203427 Transgenic animals comprising expression vectors coding heterologous polypeptides; animal models; gene therapy |
10/30/2003 | US20030203425 Polyketides; glycopeptides; glycosyltransferases |
10/30/2003 | US20030203406 Human methionine aminopeptidase type 3 |
10/30/2003 | US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/30/2003 | US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders |
10/30/2003 | US20030203396 Human galactosyltransferases |
10/30/2003 | US20030203357 Detecting and differentiating viruses or other intracellular parasites present in a specimen; compositions and methods to evaluate the susceptibility of a organisms to antimicrobial agents |
10/30/2003 | US20030202983 Protein for medical diagnosis; preventing infections; genetic engineering |
10/30/2003 | US20030202982 Genetic engineering |
10/30/2003 | US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration |
10/30/2003 | US20030202968 Diacylglycerol O-Acyltransferase 2a (DGAT2ALPHa) |
10/30/2003 | US20030202964 Mutated herpes simplex virus type 1 thymidine kinases and uses thereof |
10/30/2003 | US20030201230 Using a cross-flow filter; chromatography |
10/30/2003 | CA2785889A1 Peptide inhibitors of protein kinase c |
10/30/2003 | CA2484397A1 Methods for measuring protein kinase and phosphatase activity |
10/30/2003 | CA2482995A1 Low-cost production of peptides |
10/30/2003 | CA2482597A1 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
10/30/2003 | CA2482589A1 Compositions and method of treating alzheimer's disease |
10/30/2003 | CA2481512A1 Peptide inhibitors of protein kinase c.gamma. for pain management |
10/30/2003 | CA2481414A1 Promoter and plasmid system for genetic engineering |
10/30/2003 | CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
10/30/2003 | CA2481409A1 Thermostable dna polymerases and methods of making same |
10/30/2003 | CA2481108A1 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
10/30/2003 | CA2480003A1 Methods for controlling crystal growth, crystallization, structures and phases in materials and systems |
10/30/2003 | CA2475418A1 Mutation of dna polymerases from archaeobacteria |
10/29/2003 | EP1357190A1 Methods and markers for simple transformation and selection of recombinant ciliates |
10/29/2003 | EP1357182A1 Process for producing udp-n-acetylgalactosamine and saccharide containing n-acetylgalactosamine |
10/29/2003 | EP1357180A1 Levansucrase of lactobacillus johnsonii |
10/29/2003 | EP1357126A1 Method of assaying lysophospholipase d activity |
10/29/2003 | EP1356276A2 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action |
10/29/2003 | EP1356079A2 Srebp pathway modulation through targeting hisrs |
10/29/2003 | EP1356077A2 An electronic database of enzyme substrate and enzyme inhibitor structures |
10/29/2003 | EP1356074A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
10/29/2003 | EP1356073A2 Fermentation method for production of heterologous gene products in lactic acid bacteria |
10/29/2003 | EP1356068A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
10/29/2003 | EP1356065A2 Method of imparting disease resistance to plants by reducing polyphenol oxidase activity |
10/29/2003 | EP1356059A1 Human lipase and polynucleotides encoding the same |
10/29/2003 | EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
10/29/2003 | EP1356057A2 56634, a novel human phosphatidylinositol 4-phosphate 5-kinase family member and uses thereof |
10/29/2003 | EP1356056A2 Method for the expression of biosynthetic genes in plant seeds using novel multiple expression constructs |
10/29/2003 | EP1356055A2 Plant acyl-coa synthetases |
10/29/2003 | EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
10/29/2003 | EP1356040A2 14189, a novel human kinase and uses thereof |
10/29/2003 | EP1356032A2 Human kinases |
10/29/2003 | EP1356029A2 Phosphorylated glyoxalase i and its use |